Showing results (1751-1760 of 1,880) with videos related to
Sort By:
Pageof 188
Bioorganic & Medicinal Chemistry Letters|June 22, 2017
Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymeraseBarbara Zhizhen Zheng, Stanley V D'Andrea, Umesh Hanumegowda, et al.Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.Journal of Medicinal Chemistry|June 1, 2001
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1J H Chan, J S Hong, R N Hunter, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase InhibitorKevin W Gillman, John E Starrett, Michael F Parker, et al.Cancer Research|February 2, 1999
A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activityN Suh, Y Wang, T Honda, et al.JCI Insight|March 23, 2018
Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease riskXinmin S Li, Zeneng Wang, Tomas Cajka, et al.ACS Medicinal Chemistry Letters|January 8, 2019
Structure-Property Basis for Solving Transporter-Mediated Efflux and Pan-Genotypic Inhibition in HCV NS5B InhibitorsKap-Sun Yeung, Brett R Beno, Kathy Mosure, et al.Nature Medicine|August 8, 2018
Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potentialAdam B Roberts, Xiaodong Gu, Jennifer A Buffa, et al.Plos One|January 13, 2022
Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control studyNatalie J Atallah, Hailey M Warren, Matthew B Roberts, et al.Bioorganic & Medicinal Chemistry Letters|April 14, 2011
Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virusXiaofan Zheng, Thomas W Hudyma, Scott W Martin, et al.Pageof 188